- FREE SHIPPING ON ORDERS OVER $200
Size: 10mg
Contents: ARA-290 (10mg)
Form: Lyophilized Powder
Purity: ≥99%
Quantity: 10 Vials
ARA-290 is a synthetic peptide research compound derived from a region of erythropoietin (EPO) and studied for its interaction with tissue-protective signaling pathways. Researchers investigate ARA-290 in controlled laboratory environments to better understand cellular signaling, neuroprotective mechanisms, inflammation-related pathways, and tissue responses.
Due to its distinct molecular structure and research profile, ARA-290 has attracted scientific interest in studies involving innate repair mechanisms, cellular protection, neural signaling, and inflammatory pathway research. Ongoing laboratory investigations continue to examine its molecular characteristics and biological interactions in controlled experimental models.
ARA-290 is a synthetic peptide based on a helix-B region of erythropoietin. Unlike research focused on erythropoietin’s hematopoietic activity, ARA-290 is primarily investigated for its relationship with tissue-protective signaling mechanisms.
Researchers study ARA-290 to better understand cellular communication, receptor-mediated signaling, and biological responses associated with tissue protection and repair-related pathways.
Compound Type: Synthetic Research Peptide
Research Focus: Tissue-protective and cellular signaling research
Primary Function: Cellular and molecular pathway research
Research involving ARA-290 focuses on its interaction with signaling pathways associated with tissue-protective responses. Scientists investigate how this peptide may influence cellular signaling and molecular mechanisms within controlled experimental systems.
Laboratory studies continue to examine receptor interactions, cellular responses, and pathways related to neurobiology and inflammatory signaling to better characterize ARA-290’s research properties.
ARA-290 is commonly investigated in laboratory studies focused on:
Its distinctive research profile makes ARA-290 relevant to scientific investigations involving cellular protection, signaling pathways, and tissue-related biological mechanisms.
ARA-290 has attracted scientific interest because of its unique relationship with erythropoietin-derived signaling and tissue-protective research. Researchers continue to investigate its molecular characteristics and cellular interactions under controlled experimental conditions.
Ongoing laboratory studies aim to expand scientific understanding of peptide-mediated signaling, neurobiological pathways, cellular responses, and tissue-related mechanisms.
Product Name: ARA-290
Content: 10mg per vial
Quantity: 10 Vials
Form: Lyophilized Powder
Purity: ≥99%
Store in a cool, dry place away from direct sunlight, heat, and moisture to help maintain product stability and research-grade quality. Follow established laboratory storage protocols and manufacturer recommendations for appropriate handling.
After reconstitution, follow applicable laboratory procedures and stability requirements. Proper storage under controlled laboratory conditions can help preserve the compound’s integrity and support consistent experimental research.
ARA-290 is intended strictly for research and laboratory use only. It is not approved for human consumption, medical use, or therapeutic applications. This product is not intended to diagnose, treat, cure, or prevent any disease or condition. All handling and experimentation must be performed by qualified professionals in accordance with applicable laws, regulations, and institutional laboratory protocols.
